Skip to main content
Top
Published in: BMC Health Services Research 1/2020

Open Access 01-12-2020 | Coronavirus | Research article

Pharmacy preparedness and response for the prevention and control of coronavirus disease (COVID-19) in Aksum, Ethiopia; a qualitative exploration

Authors: Gebremicheal Gebreslassie Kasahun, Gebremichael Mulu Kahsay, Amha Teklu Asayehegn, Gebre Teklemariam Demoz, Desilu Mahari Desta, Gebremedhin Beedemariam Gebretekle

Published in: BMC Health Services Research | Issue 1/2020

Login to get access

Abstract

Background

Novel Coronavirus is a global pandemic affecting all walks of life and it significantly changed the health system practices. Pharmacists are at the front line and have long been involved in combating this public health emergency. Therefore, the study was aimed to explore pharmacy preparedness and response to prevent and control coronavirus disease 2019 (COVID-19).

Methods

A qualitative study was conducted in six pharmacies in Aksum, Ethiopia in May, 2020. We conducted six in-depth interviews with purposively selected key informants. Direct observation measures were made to assess the activities made in the medicine retail outlets for the prevention and control of the pandemic. Interview data were audio-recorded, translated and transcribed verbatim. Thematic analysis was employed to analyze the data and OpenCode version 4.02 software was used to facilitate the data analysis.

Results

The thematic analysis has resulted in seven major themes. Good preparedness measures were undertaken to control and prevent COVID-19. Study informants had good knowledge about the pandemic disease and reported they had used different resource materials to update themselves. Preparing of alcohol-based hand-rub, availing finished sanitizers and alcohol, and advising clients to maintain physical distancing were the major counseling information being delivered to prevent the disease. Some tendencies of irrational drug use and false claims of COVID-19 were observed at the beginning of the pandemic. Interview informants had reported they were working with relevant stakeholders and appropriate patient education and support were given to combat the pandemic.

Conclusion

The study revealed necessary pharmacy services has been rendered to all clients. However, availability of drugs and medical supplies were scarce which negatively affected the optimal delivery of pharmacy services. The government and other responsible bodies should work together to solve such problems and contain the pandemic.
Appendix
Available only for authorised users
Literature
1.
go back to reference Alemu S, Gebrie M. The pandemic SARS-CoV-2/COVID-19 and insights from previous homology related corona viruses (SARS-CoV and MERSCoV) outbreaks: their molecular biology and potential therapeutic targets; 2020. Alemu S, Gebrie M. The pandemic SARS-CoV-2/COVID-19 and insights from previous homology related corona viruses (SARS-CoV and MERSCoV) outbreaks: their molecular biology and potential therapeutic targets; 2020.
2.
go back to reference Meghana H-AT, Clark S. Pharmacy emergency preparedness and response (PEPR) framework for expanding pharmacy professionals’ roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond; 2020. Meghana H-AT, Clark S. Pharmacy emergency preparedness and response (PEPR) framework for expanding pharmacy professionals’ roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond; 2020.
3.
go back to reference Erku BA, Abrha S, Sinnollareddy M, Thomas J, Steadman KJ, Tesfaye WH. When fear and misinformation go viral: Pharmacists' role in deterring medication misinformation during the'infodemic'surrounding COVID-19. Res Soc Adm Pharm. 2020. Erku BA, Abrha S, Sinnollareddy M, Thomas J, Steadman KJ, Tesfaye WH. When fear and misinformation go viral: Pharmacists' role in deterring medication misinformation during the'infodemic'surrounding COVID-19. Res Soc Adm Pharm. 2020.
4.
go back to reference Shadi Doroudgar FH, Kali-Rai R, Yoshizuka K. Multi-cultural project initiative: an inclusive representation of “coronavirus guidelines for America”; 2020. Shadi Doroudgar FH, Kali-Rai R, Yoshizuka K. Multi-cultural project initiative: an inclusive representation of “coronavirus guidelines for America”; 2020.
5.
go back to reference Nadia Bukhari HR, Nayyer B, Babar Z-U-D. Pharmacists at the frontline beating the COVID-19 pandemic; 2020. Nadia Bukhari HR, Nayyer B, Babar Z-U-D. Pharmacists at the frontline beating the COVID-19 pandemic; 2020.
6.
go back to reference Wang Ying YQ, Kun Z. Drugs supply and pharmaceutical care management practices at a designated hospital during the COVID-19 epidemic; 2020. Wang Ying YQ, Kun Z. Drugs supply and pharmaceutical care management practices at a designated hospital during the COVID-19 epidemic; 2020.
7.
go back to reference FMOH, Ethiopia. Helath facility alcohol based Handrub preparation standard operating procedure. 2019. FMOH, Ethiopia. Helath facility alcohol based Handrub preparation standard operating procedure. 2019.
8.
go back to reference ASHP. Pharmacy Readiness for Coronavirus Disease 2019 (COVID-19): Recommendation for Federal Policy Makers. 2020. ASHP. Pharmacy Readiness for Coronavirus Disease 2019 (COVID-19): Recommendation for Federal Policy Makers. 2020.
9.
go back to reference Dahab MV-ZK, Flasche S, Warsame A, Ratnayake R, Favas C, Spiegel PB, et al. COVID-19 control in low-income settings and displaced populations: what can realistically be done? Confl Heal. 2020;14:1–6.CrossRef Dahab MV-ZK, Flasche S, Warsame A, Ratnayake R, Favas C, Spiegel PB, et al. COVID-19 control in low-income settings and displaced populations: what can realistically be done? Confl Heal. 2020;14:1–6.CrossRef
10.
go back to reference Jamison GH, Horton S, Jha P, Laxminarayan R, Mock CN, Nugent R. Disease Control Priorities, (Volume 9): Improving Health and Reducing Poverty: The World Bank; 2017. p. 9. Jamison GH, Horton S, Jha P, Laxminarayan R, Mock CN, Nugent R. Disease Control Priorities, (Volume 9): Improving Health and Reducing Poverty: The World Bank; 2017. p. 9.
11.
go back to reference Si-qian Zheng LY, Zhou P-x, Li H-b, Liu F, Zhao R-s. Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic. A China perspectiv; 2020. Si-qian Zheng LY, Zhou P-x, Li H-b, Liu F, Zhao R-s. Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic. A China perspectiv; 2020.
12.
go back to reference Zaiwei Song YH, Zheng S, Yanga L, Zhaoa R. Hospital pharmacists’ pharmaceutical care for hospitalized patients with COVID-19: Recommendations and guidance from clinical experience; 2020. Zaiwei Song YH, Zheng S, Yanga L, Zhaoa R. Hospital pharmacists’ pharmaceutical care for hospitalized patients with COVID-19: Recommendations and guidance from clinical experience; 2020.
13.
go back to reference Osama M. Al-Quteimat B, Amer Amer. SARS-CoV-2 outbreak: How can pharmacists help? 2020. Osama M. Al-Quteimat B, Amer Amer. SARS-CoV-2 outbreak: How can pharmacists help? 2020.
14.
go back to reference FIP, FIP Health Advisory. COVID-19: guidelines for pharmacists and the pharmacy Workoforce; 2020. FIP, FIP Health Advisory. COVID-19: guidelines for pharmacists and the pharmacy Workoforce; 2020.
15.
go back to reference Ung L. Community pharmacist in public health emergencies: quick to actionagainst the coronavirus 2019-nCoV outbreak; 2020. Ung L. Community pharmacist in public health emergencies: quick to actionagainst the coronavirus 2019-nCoV outbreak; 2020.
16.
go back to reference WHO. Medical Product Alert N°3/2020 Falsified medical products, including in vitro diagnostics, that claim to prevent, detect, treat or cure COVID-19. 2020. WHO. Medical Product Alert N°3/2020 Falsified medical products, including in vitro diagnostics, that claim to prevent, detect, treat or cure COVID-19. 2020.
17.
go back to reference FIP. COVID-19 Summary Guidance #8; Treatment guidelines and medicines to be stocked. 2020. FIP. COVID-19 Summary Guidance #8; Treatment guidelines and medicines to be stocked. 2020.
18.
go back to reference James Sanders MM, Jodlowski T, Cutrell J. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19) A Review; 2020. James Sanders MM, Jodlowski T, Cutrell J. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19) A Review; 2020.
19.
go back to reference Wang YZD, Du G, Du R, Zhao J, Jin Y, Fu S, et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020;395(10236):1569.CrossRef Wang YZD, Du G, Du R, Zhao J, Jin Y, Fu S, et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020;395(10236):1569.CrossRef
20.
go back to reference Pramath Kakodkar NK, Baig MN. A Comprehensive Literature Review on the Clinical Presentation, and Management of the Pandemic Coronavirus Disease 2019 (COVID-19); 2020. Pramath Kakodkar NK, Baig MN. A Comprehensive Literature Review on the Clinical Presentation, and Management of the Pandemic Coronavirus Disease 2019 (COVID-19); 2020.
21.
go back to reference Pedro Amariles ML-M, Salazar-Ospina A, Hincapié-García JA. How to link patients with suspicious COVID-19 to health system from the community pharmacies? A route proposal; 2020. Pedro Amariles ML-M, Salazar-Ospina A, Hincapié-García JA. How to link patients with suspicious COVID-19 to health system from the community pharmacies? A route proposal; 2020.
22.
go back to reference Erick Hedima MA, Ikunaiye N. Community Pharmacists: On the frontline of health service against COVID-19 in LMICs; 2020. Erick Hedima MA, Ikunaiye N. Community Pharmacists: On the frontline of health service against COVID-19 in LMICs; 2020.
23.
go back to reference FIP. COVID-19 Summary Guidance #2: Community pharmacy interventions and patient counselling. 2020. FIP. COVID-19 Summary Guidance #2: Community pharmacy interventions and patient counselling. 2020.
24.
go back to reference Sasmita Adhikari SM, Yu-Ju Wu, Yu-Ping Mao, Rui-Xue Ye, Qing-Zhi Wang, Chang Sun et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during theearly outbreak period: a scoping review. 2020. Sasmita Adhikari SM, Yu-Ju Wu, Yu-Ping Mao, Rui-Xue Ye, Qing-Zhi Wang, Chang Sun et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during theearly outbreak period: a scoping review. 2020.
25.
go back to reference ECDC, ECDC Technical Report. Infection prevention and control and preparedness for COVID-19 in healthcare settings. 2020. ECDC, ECDC Technical Report. Infection prevention and control and preparedness for COVID-19 in healthcare settings. 2020.
26.
go back to reference SA Health, Government of South Australia. COVID-19 Community Pharmacy COVID-19 Preparedness Update. 2020. SA Health, Government of South Australia. COVID-19 Community Pharmacy COVID-19 Preparedness Update. 2020.
27.
go back to reference Raina Merchant NL. Social media and emergency preparedness in response to novel coronavirus; 2020.CrossRef Raina Merchant NL. Social media and emergency preparedness in response to novel coronavirus; 2020.CrossRef
28.
go back to reference Mukhtar S. Preparedness and proactive infection control measures of Pakistan during COVID-19 pandemic outbreak; 2020.CrossRef Mukhtar S. Preparedness and proactive infection control measures of Pakistan during COVID-19 pandemic outbreak; 2020.CrossRef
29.
go back to reference WHO. 2019 Novel Coronavirus (2019-nCoV): Strategic Prepardness and Response Plan. 2020. WHO. 2019 Novel Coronavirus (2019-nCoV): Strategic Prepardness and Response Plan. 2020.
Metadata
Title
Pharmacy preparedness and response for the prevention and control of coronavirus disease (COVID-19) in Aksum, Ethiopia; a qualitative exploration
Authors
Gebremicheal Gebreslassie Kasahun
Gebremichael Mulu Kahsay
Amha Teklu Asayehegn
Gebre Teklemariam Demoz
Desilu Mahari Desta
Gebremedhin Beedemariam Gebretekle
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2020
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-020-05763-9

Other articles of this Issue 1/2020

BMC Health Services Research 1/2020 Go to the issue